ARNA Genomics ⛑ English— Telegram Group

This group serves as the primary communication channel between ARNA Genomics leadership and its community of early crypto investors who participated in the 2017 ICO. The company is developing medical diagnostic tests for early breast cancer detection using liquid biopsy technology, with ongoing clinical trials in the US, Germany, and China. Community discussion revolves around long-term project delays (5-7 years), token price concerns, exchange listings (currently Yobit), and the utility model where tokens can be redeemed for medical tests. While members express frustration over communication gaps and lack of immediate token value appreciation, they acknowledge the scientific rigor and recent progress including Series A funding, establishment of a California laboratory, and partnerships with major cancer clinics.